Mary Ann Gray - Insider Trading & Ownership

Entity
Individual
Location
201 W 70 Th St, Suite 23 K, New York, New York
Summary
The estimated net worth of Mary Ann Gray is at least $1.35 M dollars as of June 14, 2024. Mary Ann Gray is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $993 K. Mary Ann Gray is the Director of RAPT Therapeutics, Inc. and owns shares of RAPT Therapeutics, Inc. (RAPT) stock worth about $277 K. Mary Ann Gray is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $81.4 K. Mary Ann Gray is the Director of PALISADE BIO, INC. and owns shares of PALISADE BIO, INC. (PALI) stock worth about $2.97 K.
All Insider Reports
All Insider Reports

Ownership of Mary Ann Gray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Director $993 K Mar 7, 2022
RAPT RAPT Therapeutics, Inc. Director $277 K May 22, 2024
BCAB BioAtla, Inc. Director $81.4 K Jun 13, 2024
PALI PALISADE BIO, INC. Director $2.97 K Nov 21, 2023
CMPX Compass Therapeutics, Inc. Director Feb 9, 2024
KROS Keros Therapeutics, Inc. Director May 30, 2024

Insider Transactions Reported by Mary Ann Gray:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership